APA

Oslob J. D., Johnson R. J., Cai H., Feng S. Q., Hu L., Kosaka Y., Lai J., Sivaraja M., Tep S., Yang H., Zaharia C. A., Evanchik M. J. & McDowell R. S. (20140605). Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation. : ACS medicinal chemistry letters.

Chicago

Oslob Johan D, Johnson Russell J, Cai Haiying, Feng Shirley Q, Hu Lily, Kosaka Yuko, Lai Julie, Sivaraja Mohanram, Tep Samnang, Yang Hanbiao, Zaharia Cristiana A, Evanchik Marc J and McDowell Robert S. 20140605. Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation. : ACS medicinal chemistry letters.

Harvard

Oslob J. D., Johnson R. J., Cai H., Feng S. Q., Hu L., Kosaka Y., Lai J., Sivaraja M., Tep S., Yang H., Zaharia C. A., Evanchik M. J. and McDowell R. S. (20140605). Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation. : ACS medicinal chemistry letters.

MLA

Oslob Johan D, Johnson Russell J, Cai Haiying, Feng Shirley Q, Hu Lily, Kosaka Yuko, Lai Julie, Sivaraja Mohanram, Tep Samnang, Yang Hanbiao, Zaharia Cristiana A, Evanchik Marc J and McDowell Robert S. Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation. : ACS medicinal chemistry letters. 20140605.